Delayed mGluR5 activation limits neuroinflammation and neurodegeneration after traumatic brain injury.
Delayed mGluR5 activation limits neuroinflammation and neurodegeneration after traumatic brain injury.
复制标题
延迟的MGLUR5激活限制了创伤性脑损伤后神经炎症和神经退行性的限制。
DOI:
10.1186/1742-2094-9-43
复制
发表时间:
2012-02-28
影响因子:
9.3
通讯作者:
Faden AI
中科院分区:
文献类型:
--
作者:
Byrnes KR;Loane DJ;Stoica BA;Zhang J;Faden AI
Traumatic brain injury initiates biochemical processes that lead to secondary neurodegeneration. Imaging studies suggest that tissue loss may continue for months or years after traumatic brain injury in association with chronic microglial activation. Recently we found that metabotropic glutamate receptor 5 (mGluR5) activation by (RS)-2-chloro-5-hydroxyphenylglycine (CHPG) decreases microglial activation and release of associated pro-inflammatory factors in vitro, which is mediated in part through inhibition of reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase. Here we examined whether delayed CHPG administration reduces chronic neuroinflammation and associated neurodegeneration after experimental traumatic brain injury in mice. One month after controlled cortical impact traumatic brain injury, C57Bl/6 mice were randomly assigned to treatment with single dose intracerebroventricular CHPG, vehicle or CHPG plus a selective mGluR5 antagonist, 3-((2-Methyl-4-thiazolyl)ethynyl)pyridine. Lesion volume, white matter tract integrity and neurological recovery were assessed over the following three months. Traumatic brain injury resulted in mGluR5 expression in reactive microglia of the cortex and hippocampus at one month post-injury. Delayed CHPG treatment reduced expression of reactive microglia expressing NADPH oxidase subunits; decreased hippocampal neuronal loss; limited lesion progression, as measured by repeated T2-weighted magnetic resonance imaging (at one, two and three months) and white matter loss, as measured by high field ex vivo diffusion tensor imaging at four months; and significantly improved motor and cognitive recovery in comparison to the other treatment groups. Markedly delayed, single dose treatment with CHPG significantly improves functional recovery and limits lesion progression after experimental traumatic brain injury, likely in part through actions at mGluR5 receptors that modulate neuroinflammation.
登录
查看更多内容
影响因子:
2.2
作者:
Gentleman, SM;Leclercq, PD;Nicoll, JAR
通讯作者:
Nicoll, JAR
DOI:
10.1006/jmrb.1994.1037
发表时间:
1994-03-01
期刊:
JOURNAL OF MAGNETIC RESONANCE SERIES B
影响因子:
--
作者:
BASSER, PJ;MATTIELLO, J;LEBIHAN, D
通讯作者:
LEBIHAN, D
DOI:
10.1016/j.nurt.2008.10.038
发表时间:
2009-01
期刊:
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
影响因子:
--
作者:
Byrnes KR;Loane DJ;Faden AI
通讯作者:
Faden AI
影响因子:
3.3
作者:
Aggarwal, Manisha;Mori, Susumu;Shimogori, Tomomi;Blackshaw, Seth;Zhang, Jiangyang
通讯作者:
Zhang, Jiangyang
影响因子:
16.8
作者:
Gao HM;Hong JS
通讯作者:
Hong JS